Trademark applications and grants for Resverlogix Corp. Resverlogix Corp has 7 trademark applications. The latest application filed is for "RESVERLOGIX"
Patent Application | Date |
---|---|
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES 20210361656 - 17/335960 HANSEN; Henrik C. | 2021-11-25 |
ANTI-INFLAMMATORY AGENTS 20210070716 - 16/951701 Hansen; Henrik C. | 2021-03-11 |
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES 20200352946 - 16/707559 Hansen; Henrik C. | 2020-11-12 |
NOVEL ANTI-INFLAMMATORY AGENTS 20200129512 - 16/441793 Hansen; Henrik C. ;   et al. | 2020-04-30 |
NOVEL ANTI-INFLAMMATORY AGENTS 20190119222 - 16/159002 HANSEN; Henrik C. | 2019-04-25 |
NCAGE Code | L07T2 | RESVERLOGIX CORP |
CAGE Code | L07T2 | RESVERLOGIX CORP |
SEC | 0001372821 | RESVERLOGIX CORP. of ALBERTA, CANADA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.